ABL Diagnostics Unveils Next-Generation HIV Genotyping Innovation with the Industry’s Broadest Portfolio
International HIV publication further validates the DeepChek® brand for HIV genotyping and long- & short-read NGS, reinforcing ABL’s leadership in HIV genomics. WOIPPY, FRANCE, May 20, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 …